These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2826698)

  • 21. ADP-ribosylation with pertussis toxin modulates the GTP-sensitive opioid ligand binding in digitonin-soluble extracts of rat brain membranes.
    Wong YH; Demoliou-Mason CD; Barnard EA
    J Neurochem; 1988 Jul; 51(1):114-21. PubMed ID: 2837532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
    Jauzac P; Frances B; Puget A; Moisand C; Meunier JC
    J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of opioid-binding materials from rat brain.
    Fujioka T; Inoue F; Kuriyama M
    Biochem Biophys Res Commun; 1985 Sep; 131(2):640-6. PubMed ID: 2996518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiate binding sites in the chick, rabbit and goldfish retina.
    Slaughter MM; Mattler JA; Gottlieb DI
    Brain Res; 1985 Jul; 339(1):39-47. PubMed ID: 2992696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites.
    Spain JW; Petta DE; Coscia CJ
    Mol Pharmacol; 1988 Jul; 34(1):23-8. PubMed ID: 2839762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonist-selective protection of the opioid receptor-coupled G proteins from inactivation by 5'-p-fluorosulphonylbenzoyl guanosine.
    Wong YH; Demoliou-Mason CD; Hanley MR; Barnard EA
    J Neurochem; 1990 Jan; 54(1):39-45. PubMed ID: 2152798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T; Wüster M; Gramsch C; Herz A
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation.
    Gioannini TL; Liu YF; Park YH; Hiller JM; Simon EJ
    J Mol Recognit; 1989 Jul; 2(1):44-8. PubMed ID: 2561526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple interconvertible affinity states for the delta opioid agonist-receptor complex.
    Spain JW; Coscia CJ
    J Biol Chem; 1987 Jul; 262(19):8948-51. PubMed ID: 3036838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulatory role of glutathione on mu-opioid, substance P/neurokinin-1, and kainic acid receptor binding sites.
    Liu YF; Quirion R
    J Neurochem; 1992 Sep; 59(3):1024-32. PubMed ID: 1379628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varying expression of opioid receptors and GTP-binding proteins in human pheochromocytomas.
    Kamikubo K; Murase H; Niwa M; Miura K; Miura Y; Satoh T; Tomita A; Nakamura S; Miyashita T; Imai T
    NIDA Res Monogr; 1986; 75():133-6. PubMed ID: 2828958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of angiotensin II receptors in bovine adrenal cortex by dithiothreitol: further evidence for the essential nature of disulfide bonds.
    Chang RS; Lotti VJ; Keegan ME
    Biochem Pharmacol; 1982 May; 31(10):1903-6. PubMed ID: 6285929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
    Vachon L; Costa T; Herz A
    Mol Pharmacol; 1987 Feb; 31(2):159-68. PubMed ID: 3027528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localisation and pharmacological characterisation of [3H]bremazocine binding in the bovine adrenal medulla.
    Bunn SJ
    Neurosci Lett; 1991 Apr; 125(2):139-42. PubMed ID: 1652708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gpp(NH)p promotes the formation of a low affinity state for the delta opioid agonist-receptor complex.
    Spain JW; Bennett DB; Coscia CJ
    Neuropeptides; 1984 Dec; 5(1-3):145-8. PubMed ID: 6099484
    [No Abstract]   [Full Text] [Related]  

  • 38. Solubilization in high yield of opioid receptors retaining high-affinity delta, mu and kappa binding sites.
    Demoliou-Mason CD; Barnard EA
    FEBS Lett; 1984 May; 170(2):378-82. PubMed ID: 6144572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum.
    Crema G; Gioannini TL; Hiller JM; Simon EJ
    NIDA Res Monogr; 1986; 75():9-12. PubMed ID: 2829015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.